Heartflow, Inc.

HTFL Healthcare Health Information Services

Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.

Revenue
+47.6%
EPS
+87.7%
Free cash flow
+62.6%

Quarter to June 2026, against a year earlier

51.49 0.46 −0.89%
Market cap
$4.5B
P/E
0.0×
Fwd P/E
−72.9×
Dividend yield
—
F-score
5/9
Altman Z
7.22
Beneish M
−2.55
Dividend safety
n/a

Heartflow, Inc. (HTFL) EV/EBITDA

Alert me on EV/EBITDA

Heartflow, Inc. has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
6 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

EV/EBITDA against peers

Company EV/EBITDA
HTFL Heartflow, Inc. n/m
SDGR Schrodinger, Inc. compare n/m
OMCL Omnicell, Inc. compare 12.2×
TDOC Teladoc Health, Inc. compare 13.3×
WAY Waystar Holding Corp. compare 15.0×
HQY HealthEquity, Inc. compare 18.2×
DOCS Doximity, Inc. compare 24.0×
PRVA Privia Health Group, Inc. compare 41.1×
HNGE Hinge Health Inc. compare 54.5×
Health Information Services industry median 13.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on HTFL